ArriVent BioPharma(AVBP) - 2023 Q4 - Annual Results

Exhibit 99.1 ArriVent Biopharma Reports Full Year 2023 Financial Results NEWTOWN SQUARE, PA, March 28, 2024 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. ("Company" or "ArriVent") (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today reported financial results for the full year ended December 31, 2023, and highlighted recent company progress. "The fourth quarter was transformational for ArriVent, as we positioned our comp ...